NCT00245947View on ClinicalTrials.gov

Study Evaluating ERB-041 in Active Crohn's Disease

PHASE1CompletedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions

Crohn's Disease

Interventions

DRUG

ERB-041

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00245947 - Study Evaluating ERB-041 in Active Crohn's Disease | Biotech Hunter | Biotech Hunter